Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bolt-on deals
Biotech
BMS more likely to bet on bolt-ons after recent buying spree
Bristol Myers Squibb is focused on integrating its new acquisitions, but CEO Chris Boerner said there's still interest in more business development.
Max Bayer
Feb 2, 2024 10:59am
Novartis knows what's ahead as peers enter radiopharmaceuticals
Oct 24, 2023 7:00am
Biopharma won’t stop betting big on M&A earnouts as payouts slow
Oct 17, 2023 6:00am
M&A values halve, volumes plunge. Will we ever see deals again?
Dec 8, 2022 8:25am
Galapagos takes M&A plunge, spending $251M for CAR-T push
Jun 22, 2022 4:36am